Clinical Trial

Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients

Name: Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients — clinical trial record (NCT07072221)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of bendamustine combined with chidamide and lenalidomide in R/R PTCL patients.

Trial Details

NCT Number	NCT07072221
Lead Sponsor	The First Affiliated Hospital of Soochow University
Conditions	Peripheral T-cell Lymphoma
Enrollment	40 participants
Start Date	2024-11-01
Primary Completion	2029-08-01 (estimated)
Study Completion	2029-11-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-18